Peptide-S
Finnrick has tested 128 samples from Peptide-S across 11 products.
Finnrick Vendor Profile
to
Peptide-S
Tracking 11 products
128 total samples tested
Last test 10 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Mazdutide | 4 | 16 Jul 2025 | 25 Nov 2025 | |||||
| Survodutide | 4 | 16 Jul 2025 | 25 Nov 2025 | |||||
| Ipamorelin | 4 | 5 Aug 2025 | 20 Feb 2026 | |||||
| Semaglutide | 5 | 16 Jul 2025 | 15 Jan 2026 | |||||
| Cagrilintide | 4 | 14 Jun 2025 | 25 Nov 2025 | |||||
| GHK-Cu | 8 | 16 Jul 2025 | 22 Feb 2026 | |||||
| Sermorelin | 3 | 24 Jul 2025 | 20 Feb 2026 | |||||
| Tesamorelin | 7 | 13 Jun 2025 | 15 Jan 2026 | |||||
| Tirzepatide | 39 | 9 Jun 2025 | 4 Mar 2026 | |||||
| BPC-157 | 5 | 16 Jul 2025 | 18 Sep 2025 | |||||
| Retatrutide | 41 | 11 Jun 2025 | 10 Mar 2026 | |||||
The Peptide-S samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.9
Based on 15 overall satisfaction reports
Ease of Purchase4.8(15)
Payment Methods4.7(15)
Delivery Speed4.1(15)
Packaging Quality4.7(15)
Customer Service4.9(13)
People who submitted test requests to Finnrick gave Peptide-S an average satisfaction rating of 4.9 out of 5 across 15 reports associated with samples received and tested by Finnrick. Customers rated delivery speed (4.1/5) comparatively lower.
Most recent Peptide-S tests
Samples are tested in commercial labs
128
tests
11
products
Scores
AVGMINMAX
First
9 Jun 2025
Last
10 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 10 Mar 2026 | Retatrutide | View | 20mg | 19.7mg | -1.5% | 99.90% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 4 Mar 2026 | Tirzepatide | View | 60mg | 56.3mg | -6.2% | 99.90% | Jan 2, 2026 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 2 Mar 2026 | Tirzepatide | View | 30mg | 35.2mg | +17.3% | 99.90% | Jan 2, 2026 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 2 Mar 2026 | Tirzepatide | View | 20mg | 20mg | 99.90% | Jan 2, 2026 | No Label / Silver Crimp / Violet Cap | Lab E | Public | ||
| 26 Feb 2026 | Tirzepatide | View | 40mg | 41mg | +2.5% | 99.90% | Jan.2,2026 | No Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 22 Feb 2026 | Retatrutide | View | 30mg | 32.4mg | +8.0% | 99.41% | Dec2, 15. 2025 | (no data) | Lab E | Public | |
| 22 Feb 2026 | GHK-Cu | View | 100mg | 100mg | 99.76% | Dec2, 15. 2025 | (no data) | Lab E | Public | ||
Corrections
- 1 Aug 2025: Survodutide
- Peptide-S Survodutide results are being reviewed, will be updated soon.
- 1 Aug 2025: Mazdutide
- Peptide-S Mazdutide results are being reviewed, will be updated soon.